Lbp Am Sa Purchases 33,779 Shares of Colgate-Palmolive Company $CL

Lbp Am Sa increased its position in Colgate-Palmolive Company (NYSE:CL) by 14.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 262,102 shares of the company’s stock after buying an additional 33,779 shares during the period. Lbp Am Sa’s holdings in Colgate-Palmolive were worth $20,711,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CL. Brighton Jones LLC boosted its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the period. Woodline Partners LP boosted its holdings in Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares during the period. Schnieders Capital Management LLC. lifted its stake in Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after purchasing an additional 245 shares in the last quarter. Nebula Research & Development LLC lifted its stake in Colgate-Palmolive by 165.5% in the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock worth $939,000 after purchasing an additional 6,437 shares in the last quarter. Finally, Sei Investments Co. lifted its stake in Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock worth $59,732,000 after purchasing an additional 116,968 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. The Goldman Sachs Group reiterated a “buy” rating and issued a $100.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 20th. Bank of America decreased their price target on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Finally, Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 13th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.56.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the sale, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. The trade was a 63.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 184,683 shares of company stock valued at $17,486,693. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $83.49 on Thursday. The company’s 50-day moving average price is $90.39 and its 200-day moving average price is $83.67. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The company has a market cap of $66.98 billion, a PE ratio of 31.87, a price-to-earnings-growth ratio of 4.19 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the firm posted $0.91 EPS. The business’s quarterly revenue was up 5.8% on a year-over-year basis. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s payout ratio is presently 80.92%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.